Common Contracts

2 similar Security Agreement contracts by Kazia Therapeutics LTD

AMERICAN DEPOSITARY SHARES REPRESENTING ORDINARY SHARES OF KAZIA THERAPEUTICS LIMITED
Security Agreement • December 2nd, 2025 • Kazia Therapeutics LTD • Pharmaceutical preparations

THIS WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES REPRESENTING ORDINARY SHARES IN THE CAPITAL OF THE COMPANY, AS DEFINED BELOW, (the “Warrant”) certifies that, for value received, ___________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after 180 days after December 2, 2025 and on or prior to 5:00 p.m. (New York City time) on December 2, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Kazia Therapeutics Limited ACN 063 259 754, a public company incorporated under the laws of the Commonwealth of Australia (the “Company”), up to _________ American Depositary Shares (as subject to adjustment hereunder, the “Warrant ADSs”), with each American Depositary Share (“ADS”) representing five hundred (500) ordinary shares, no par value per share, of the Company (the “Ordinary Shares”). The purchase price of one ADS under this Warrant shall be eq

PREFUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES KAZIA THERAPEUTICS LIMITED
Security Agreement • December 2nd, 2025 • Kazia Therapeutics LTD • Pharmaceutical preparations

THIS PREFUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Kazia Therapeutics Limited ACN 063 259 754, a company incorporated under the laws of Australia (the “Company”), up to (the “Warrant Shares”) of the Company’s ordinary shares, no par value per share (the “Ordinary Shares”), represented by American Depositary Shares (each, an “ADS” and, collectively, the “ADSs” and the ADSs issuable upon exercise of this Warrant, the “Warrant ADSs”), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b